Oct 25, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed the most recent trading day at $8.03, moving -1.65% from the previous trading session.
Oct 25, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Oct 24, 2019 - Teva Pharmaceutical's proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review.
Oct 21, 2019 - The company announced an unexpectedly favorable settlement in a lawsuit related to the opioid epidemic.
Oct 21, 2019 - Teva Pharmaceutical Industries (TEVA +17.3%) has settled a lawsuit brought by two Ohio counties over its alleged role in the opioid epidemic there.Under the terms of the agreement, it has agreed to pa
Oct 21, 2019 - Under that deal, Teva would donate $23 billion in opioid addiction treatment drugs and pay $250 million over 10 years.
Oct 21, 2019 - J&J (JNJ) voluntarily recalls one lot of its baby powders, which is the subject of numerous lawsuits claiming that its talc-based products contain asbestos that causes cancer.
Oct 17, 2019 - Gabelli & Co issues rating change for TEVA
Oct 16, 2019 - Three major drug distributors – McKesson, AmerisourceBergen and Cardinal Health – are in discussions to pay $18 billion, while drugmaker Johnson & Johnson has offered $4 billion.
Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.